Susquehanna International Group’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,400
Closed -$69.6K 13305
2025
Q4
$69.6K Sell
15,400
-42,100
-73% -$216K ﹤0.01% 11630
2025
Q3
$310K Buy
57,500
+31,300
+119% +$169K ﹤0.01% 10030
2025
Q2
$142K Sell
26,200
-15,100
-37% -$59.9K ﹤0.01% 11538
2025
Q1
$114K Buy
41,300
+10,100
+32% +$35.1K ﹤0.01% 11450
2024
Q4
$106K Sell
31,200
-37,700
-55% -$109K ﹤0.01% 11297
2024
Q3
$203K Buy
68,900
+52,000
+308% +$171K ﹤0.01% 10449
2024
Q2
$57.5K Sell
16,900
-12,800
-43% -$41.9K ﹤0.01% 11350
2024
Q1
$90K Sell
29,700
-7,400
-20% -$26K ﹤0.01% 11279
2023
Q4
$156K Sell
37,100
-37,900
-51% -$206K ﹤0.01% 10937
2023
Q3
$512K Buy
75,000
+3,500
+5% +$30.9K ﹤0.01% 8166
2023
Q2
$745K Buy
71,500
+10,500
+17% +$93.9K ﹤0.01% 7370
2023
Q1
$425K Buy
61,000
+48,300
+380% +$421K ﹤0.01% 8965
2022
Q4
$76.6K Sell
12,700
-69,100
-84% -$511K ﹤0.01% 11164
2022
Q3
$645K Sell
81,800
-189,400
-70% -$2.21M ﹤0.01% 7772
2022
Q2
$3.69M Sell
271,200
-45,000
-14% -$744K ﹤0.01% 3715
2022
Q1
$6.2M Sell
316,200
-139,000
-31% -$2.78M ﹤0.01% 3285
2021
Q4
$15.6M Sell
455,200
-70,800
-13% -$2.85M ﹤0.01% 2123
2021
Q3
$28.7M Sell
526,000
-84,500
-14% -$5.09M ﹤0.01% 1630
2021
Q2
$44.9M Buy
610,500
+134,200
+28% +$13.4M 0.01% 1272
2021
Q1
$43.6M Buy
476,300
+222,400
+88% +$21.6M 0.01% 1207
2020
Q4
$20.6M Buy
253,900
+84,500
+50% +$6.47M ﹤0.01% 1710
2020
Q3
$7.89M Buy
+169,400
New +$9.45M ﹤0.01% 2487

Susquehanna International Group's CVAC Position: Q1 2026 in Review

Susquehanna International Group sold out of CureVac (CVAC) in Q1 2026, closing a stake of 23,604 shares — an estimated $107K sold.

Susquehanna International Group first reported a position in CVAC in Q3 2020 and held it in 20 quarters. The position peaked at $28.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Susquehanna International Group reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 23,604 CureVac shares in Q1 2026, an estimated $107K.
  • Susquehanna International Group first reported a position in CureVac in Q3 2020 and held it in 20 quarters.
  • Susquehanna International Group's CureVac position peaked at $28.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.